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Abstract
Influenza virus is a major cause of morbidity and mortality worldwide, yet little quantitative understanding of transmission is
available to guide evidence-based public health practice. Recent studies of influenza non-contact transmission between
ferrets and guinea pigs have provided insights into the relative transmission efficiencies of pandemic and seasonal strains,
but the infecting dose and subsequent contagion has not been quantified for most strains. In order to measure the aerosol
infectious dose for 50% (aID50) of seronegative ferrets, seasonal influenza virus was nebulized into an exposure chamber
with controlled airflow limiting inhalation to airborne particles less than 5 mm diameter. Airborne virus was collected by
liquid impinger and Teflon filters during nebulization of varying doses of aerosolized virus. Since culturable virus was
accurately captured on filters only up to 20 minutes, airborne viral RNA collected during 1-hour exposures was quantified by
two assays, a high-throughput RT-PCR/mass spectrometry assay detecting 6 genome segments (Ibis T5000
TM Biosensor
system) and a standard real time RT-qPCR assay. Using the more sensitive T5000 assay, the aID50 for A/New Caledonia/20/99
(H1N1) was approximately 4 infectious virus particles under the exposure conditions used. Although seroconversion and
sustained levels of viral RNA in upper airway secretions suggested established mucosal infection, viral cultures were almost
always negative. Thus after inhalation, this seasonal H1N1 virus may replicate less efficiently than H3N2 virus after mucosal
deposition and exhibit less contagion after aerosol exposure.
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Introduction
Influenza is a highly contagious respiratory infection annually
causing over 1.6 million infections [1] and 36,000 deaths [2] in the
United States and causing periodic pandemics with increased
mortality worldwide [3]. In spite of its major morbidity and
mortality our knowledge of influenza transmission is poor [4], with
little quantitative data available on exhaled virus from contagious
hosts [5] or level of inhaled virus needed to initiate infection. Only
one study in 1966 has measured the amount of inhaled seasonal
influenza causing symptomatic infection in the susceptible human
host [6]. Recent publications have quantified the aerosol virus
dose of H3N2 and H5N1 strains causing infection in the ferret
model [7,8].
Quantitative information may help resolve the ongoing debate
on the relative importance of the different modes of infection.
Influenza transmission occurs by three modes that are difficult to
separate in epidemiological analysis. Contact with a contagious
individual or surfaces contaminated by virus and inhalation of
airborne droplets from a cough or sneeze (droplet transmission)
are thought to be common modes of transmission [9,10]. Droplets
greater than 5 mm in diameter briefly remain airborne and are
arrested in the upper airways after inhalation, while particles less
than 5 mm in diameter (droplet nuclei) are exhaled during normal
breathing and talking as well as coughing and sneezing [11], are
airborne for minutes to hours depending on size and density, and
can reach deeper lung tissues [12] (aerosol transmission).
Epidemiological evidence for aerosol transmission is accumulating
[13,14] but further support will derive from animal models.
Influenza models in the guinea pig and ferret approximate both
the susceptibility and transmissibility of influenza. Transmission
between guinea pigs has been used effectively to study relative
transmission efficiency between strains and dependence on
humidity and temperature [15,16], but the guinea pig does not
develop inflammatory disease with symptoms [17]. The ferret
approximates human infection with respect to susceptibility,
pathogenesis and transmission [7,18]. In the ferret transmission
of seasonal and pandemic 2009 H1N1 flu strains (but not HPAI
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recent seminal study of seasonal H3N2 infection in the ferret has
quantified exhaled virus and measured the minimal aerosol
infectious dose [7].
We calculated in the present study the aerosol infectious dose
for 50% of ferrets (aID50) for a seasonal human H1N1 influenza
virus. We designed a two-chamber apparatus to nebulize virus into
a controlled airflow environment permitting the measurement of
airborne virus and directly estimate the dose of virus inhaled by
the susceptible ferret. To approximate the typical duration of
human exposure in classroom or workplace, we limited exposures
of ferrets to 1 hour. To optimize the detection of very low levels of
airborne virus, particles were collected on filters and in liquid
impingers and analyzed by culture and two RT-PCR-based assays.
Although evidence was found for viral replication in upper airway
mucosa, viral cultures were negative suggesting that aerosol
transmission resulting in contagious infection is not a characteristic
of this particular H1N1 seasonal virus.
Materials and Methods
Influenza virus
A/New Caledonia/20/99 (H1N1) (NC99), a seasonal influenza
strain included in the seasonal influenza vaccine for 7 years, was
obtained from the Centers for Disease Control. The stock virus
was passaged twice in 10-day old embryonated chicken eggs, once
in Madin-Darby Canine Kidney (MDCK) cells and a final passage
in eggs. Stock viruses had titers of 9.0610
5 focus-forming units
(FFU) per mL on MDCK cells. Stocks were frozen at 280C until
use, and were re-titered after each experiment to confirm the
actual titer inoculated into the nebulizer.
Exposure Apparatus
A small two-chamber Lexan exposure apparatus permitting
quantitative monitoring of virus in aerosols artificially generated
by nebulizer or exhaled by infected animals was designed and
fabricated at Lovelace Respiratory Research Institute (LRRI)
(Figure 1). The apparatus consisted of an ‘origin’ chamber 30 cm
in length for each of the three dimensions, connected directly to a
6-jet Collison small particle generator (AGI, Inc.). The ‘origin’
chamber was connected through a 10610 cm square metal tube
17.5 cm in length to the 30 cm
3 ‘‘recipient’’ chamber with a small
fan on the roof of the chamber to increase air circulation. The air
was drawn by line vacuum through HEPA filters in the wall of the
origin chamber at a rate of 12 L/min and exited the recipient
chamber through HEPA filters. Nebulization into the origin
chamber and through the metal tunnel permitted only particles
less than 5 mm diameter to reach the recipient chamber
(Figure 1b). Wire mesh screens at both ends of the tunnel
prevented the ferret from contacting surface-contaminating virus
on the walls of the tunnel and donor chamber. The entire
apparatus was de-contaminated with bleach and alcohol after
every exposure.
Ferret Infection
All procedures were conducted under protocols approved by the
Institutional Animal Care and Use Committee (IACUC) at LRRI,
all facilities were accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International (AAA-
LAC), and guidelines for ferret housing, environment and comfort
described in the Guide For The Care and Use of Laboratory
Animals, Seventh Edition, National Research Council, were
strictly adhered to. Ferrets weighing 800 to 1200 g were purchased
from Triple F Farms (Sayre, PA) and housed in BSL2 conditions
for observation for at least 10 days and for serological confirmation
by the hemagglutination inhibition assay for the absence of serum
antibody to circulating influenza A and B strains. Ferrets were
exposed to aerosolized virus for 1 h with air-flow rate of 5.7–
6.0 L/min in the recipient chamber of the exposure apparatus.
The ferrets were unanesthetized and spent variable amounts of
time exploring the chamber and sleeping on the wire floor of the
chamber. After exposure each ferret was housed in a separate cage
in a ventilated rack (Allentown Cage Inc, Allentown, NJ) to
prevent any direct or airborne contact with other ferrets. The
upper respiratory tract was sampled by daily nasal wash and throat
swab for 5 consecutive days beginning 24 hours after exposure.
Nasal wash solution (1 mL of 0.1% bovine serum albumin fraction
5, 1% Antibiotic/Antimycotic (100 units penicillin G, 100 mg
streptomycin sulfate, 0.25 mg amphotericin B, Invitrogen), in PBS)
was flushed through each nare, retrieved in a collection cup and
divided equally into RNABee for later RNA extraction and rapidly
frozen for later viral culture. The throat was swabbed vigorously
with a foam-tipped applicator moistened with nasal wash solution,
vortexed for 20 sec in 1 mL nasal wash solution, divided as above,
and frozen at 280uC until analysis. The criterion for ferret
‘infection’, i.e., evidence for continuing viral replication in upper
airway mucosa, was all of the five daily samples positive by culture
or RT-qPCR.
Aerosol analysis
Viral aerosols were collected from the metal tube by a glass
impinger (AGI, Inc) at a flow rate of 2–6 L/min. Either 1 sterilized
gelatin filter (25 mm, SKC Inc., Eighty Four, PA), or 1–3 25 mm
Polytetrafluoroethylene (PTFE) Teflon filters (2.0 mm pore size,
SKC Inc.) were used each drawing an air flow rate of 2 L/min.
Gelatin filters dried and shrunk during 1 h of nebulization, thus all
filter data presented are from PTFE filters. Particle counting and
sizing was performed with a 31-channel real time aerosol
spectrometer (Model 1.109, GRIMM Technologies, Inc, Ger-
many). The flow rate of the GRIMM optical counter was 1.2 L/
min. In each exposure the Collison nebulizer and AGI contained
20 mL media consisting of MEM, 0.2% NaHCO3,2 0 m M
HEPES, 1% Antibiotic/Antimycotic, 20 mM L-Glutamine,
0.001% BSA, and 100 mL of Antifoam A (Sigma). Collison and
impinger fluid samples were collected before and after nebuliza-
tion and aliquoted into RNABee (1:1 dilution) or frozen at 280uC
and stored for viral culture. PTFE filters collected aerosolized virus
at 2 L/min air flow for 1 h. After exposure the filters were
vortexed for 20 seconds in 1 mL impinger fluid, the filter
removed, and sample aliquoted equally into RNABee or frozen
at 280uC for viral culture.
Viral culture
Virus was titered by a microplaque focus-forming unit (FFU)
assay. After the sample containing virus was incubated on MDCK
monolayers with 1.25 mg/mL TPCK-trypsin at 35uC for 1 h,
1.2% Avicel was overlaid and incubated for 18 h at 35uC. After
overlay removal and fixation with 4% paraformaldehyde for
30 min at 4uC, the wells were washed twice with 0.05% Tween-20
in PBS, incubated 20 min with 0.5% Triton-X-100 and 20 mM
glycine in PBS, and washed twice. Plaques containing influenza
antigen were identified by incubation with anti-influenza M1
antibody (MAB8251, Millipore) diluted 1:1500 in 10% normal
horse serum and 0.05% Tween-20 in PBS followed by secondary
antibody diluted 1:150 in 10% horse serum, stained with 0.4 mg/
mL AEC in 0.05 M sodium acetate and 0.03% H2O2, and
counted under 206magnification.
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RNA in throat swab and nasal wash samples was extracted by
vortexing 10 sec in 200 mL of BCP (1-Bromo-3-chloropropane),
centrifugation at 13,000 rpm and 4uC for 10 min removal of the
aqueous layer and extracted in the Kingfisher processor (Thermo
Scientific) by the ‘‘Magmax Clear’’ protocol according to the
manufacture’s instructions. Large volume samples from nebulizer
and liquid impingers were extracted using the Qiagen RNeasy
Maxi kit adapted to contain 10 mL/mL of carrier RNA in the
initial lysis buffer followed the manufacture’s ‘‘RNA Clean-up’’
protocol and concentration by ethanol precipitation into a 60 mL
volume. PTFE filter samples were extracted by Qiagen QIAamp
Viral RNA kit with carrier RNA.
For analysis of RNA by the Ibis T5000
TM Biosensor system,
pan-influenza virus PCR primer sets were developed that are
capable of amplifying all three influenza virus species (A, B, and C)
and subtypes (HxNy) from different animal hosts (human, avian,
swine, etc.) [22,23,24]. A panel of eight primers was selected
comprising one pan-influenza primer pair, five influenza A-specific
primer pairs, and two influenza B-specific primer pairs, thus
targeting 6 of the 8 genomic RNA segments. Following initial RT-
PCR, mass spectroscopy (ESI-MS) is used to ‘‘weigh’’ amplicons
with enough accuracy to yield an unambiguous base composition
(Aw,G x,C y,T z) used to identify and/or differentiate a pathogen
by interrogation of a large database of known influenza sequences.
The LOD of the assay is 10 genome equivalents (GEq).
For analysis of RNA by the standard RT-qPCR assay targeting
one genomic RNA segment, samples were amplified in triplicate
using either the ABI TaqMan One-Step RT-qPCR Master Mix
Reagents Kit (33.3 nM primer and 13.3 nM probe) or the Qiagen
Quantitect Virus Kit (333 nM primer and 80 nM probe). A
standard curve for each plate contained nine log10 dilutions of
influenza M1 gene RNA prepared by Invitrogen plasmid blunt-
TOPO and Ambion Mega-short-Script kit. The M1 gene forward
primer: TTC ACA GCA TCG GTC TCA CAG ACA, reverse:
TCC AGC CAT CTG TTC CAT AGC CTT and probe: /56-
FAM/AAC AGA ATG GTG CTG GCT AGC ACT /3BHQ_2/
(Integrated DNA Technologies, Coralville, IA). RT for 209 at 50uC
was followed by PCR at 95uC for 5 min, 40 cycles of 95uC for
15 sec, 60uC for 45 sec on an ABI 7900HT Fast Real-Time PCR
System with ABI SDS 2.3 software. After manually setting the
threshold for the midpoint for each standard curve, the mean slope
was23.5fora mean of93.07%efficiency, the mean y-intercept was
41.5, and the mean r
2 was 0.998 for all plates. A sample was positive
at a Ct of 35 when two out of three filters were positive yielding an
LOD of 30 Genome Equivalents (Geq; genome copies)/sample.
Calculation of Inhaled Virus
The viral RNA collected from the aerosol by the T5000 PCR-
based assay was used to calculate virus inhaled according to the
formula:
Infectiousvirus inhaled~ Geq vRNA in 1 h aerosol ðÞ  
FFU=Geq ratio ðÞ   MV=filter flow rate ðÞ
The FFU/Geq ratio was derived from filter collections of high
levels of aerosolized virus with positive culture and viral RNA data
Figure 1. Schematic of the exposure chamber. The exposure apparatus is a pair of boxes with controlled airflow drawn through the HEPA filters
in the origin (left) chamber wall to the vacuum line filters outside of the recipient chamber (right). The apparatus is housed in a Biosafety Cabinet
class 2B for safety during ferret insertion and removal.
doi:10.1371/journal.pone.0024448.g001
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determined by the minute ventilation divided by the airflow/min
through the filter (2 L/min). Minute ventilation (MV) was
estimated from unpublished data and literature reports, adjusted
for ferret weight and sedation status. For anesthetized ferrets
weighing 280 g and 560 g, tidal volumes (TV) have been reported
as 4.0 and 6.0 mL, respectively [25,26]. TV for our ferrets
weighing between 0.8 and 1.2 kg was calculated as 9.0 mL
according to the L-power relationship between body weight and
lung volume. The breathing rate (RR) was observed to be a mean
of 35/min (range 28–43), and the lack of sedation was adjusted by
multiplying the TV by 1.5 (J Mauderly, personal communication),
yielding a calculated MV (TV*RR*1.5) of 472 mL/min. The ID50
was estimated using Proc Probit in SAS 9.1 (Cary, NC).
Results
Aerosol Characteristics
In initial experiments the viral aerosol generated by the Collison
nebulizer located outside the left chamber resulted in a visible
cloud of particles in both chambers (Figure 2a). Relative
humidity (RH) at the onset of nebulization was 40–45% and
increased to 75–80% at the end of the hour. A diffusion dryer (In-
Tox Products, Moriarty, NM) was then placed between the
Collison and the chamber, resulting in no increase in RH, start
RH mean (range) of 43% (41–48) compared to end RH mean
41% (31–53). The particle size showed a bi-modal distribution
with a majority of particles in the sub-micrometer size (0.25 to
1 mm, median diameter 0.44 mm) and less than 5% between 1 and
5 mm (median diameter 1.70 mm) (Figure 2b). Particle concen-
tration during aerosolization ranged from 1.4–2.0610
7 particles/
mL (Figure 2c). The mean rate of fluid aerosolized by the
Collison generator was 170 ml/min but the volume of each run
varied from 5–14 mL at 60 min, so the amount of virus
aerosolized was calculated according to the volume nebulized in
each experiment. Thus exposures in our apparatus were
exclusively due to virus airborne in particle nuclei applicable to
aerosol transmission.
Detection of Aerosolized Virus
We compared the relative sensitivity of two PCR-based
methods, the Ibis T5000 assay that detects 6 genomic RNA
segments for Influenza A, and a standard RT-qPCR assay that
detects a single segment (M gene) in samples expected to contain
high levels of virus (throat swab and nasal wash) and low levels of
virus (airborne virus captured in liquid impinger and on PTFE
filters (Figure 3). For all (N=419) samples analyzed by both
assays, 212 (50.6%) were positive by either one or both assays, and
85 samples (20.3%) were positive only by the T5000 assay. The
single target RT-qPCR assay was never positive if the T5000 assay
was negative, so the T5000 system was significantly more sensitive
than the RT-qPCR assay (P=,0.0001, Fisher Exact Test).
Among sample sources expected with high viral RNA content,
there was no difference in sensitivity of the two assays, whereas for
samples with low RNA levels (PTFE Filters and liquid impingers)
the T5000 was significantly more sensitive (P=,0.001, Fisher
Exact Test). There was a linear correlation between the calculated
virus aerosolized and the viral genomes collected on the PTFE
filters measured by the T5000 assay after one hour of collection
(Linear Regression Test, Slope=0.74, r
2=0.22, F value=9.93;
data not shown). Examining only those experiments in which the
recipient ferrets were infected, the linear relationship was more
robust both for virus measured by T5000 assay (Linear Regression
Test, slope=0.775, r
2= 0.861, F=37.3) and the RT-qPCR assay
(slope=1.57, r
2=0.833, F=20.0). Since the T5000 assay was
more sensitive at low concentrations than the RT-qPCR assay,
subsequent analysis used the T5000 data.
Comparison of impinger and PTFE filter efficiencies
Different efficiencies of collection have been reported for
impingers and filters, suggesting that each experimental set-up
should be calibrated for relative efficiency. In our two-chamber
exposure apparatus filters and impingers were compared during
aerosolization of high levels of virus, with the RH controlled at
approximately 40–45% with the diffusion dryer. Collections at 10,
20, and 30 min of viable virus were highly variable in the impinger
(Table 1) and the collected virus did not appear to be additive
with increasing time of collection. Collections of viable virus on the
filters increased proportionately from 10 to 20 min, decreased at
30 min (Table 1) and were negative at 60 min (data not shown).
Loss of culturable virus by 60 min may be due to inactivation by
dessication, as the viral RNA on the filters increased proportion-
ately with time. Viral RNA in the impinger liquid was consistently
two log10 below that collected on parallel filters at each time
interval (data not shown), possibly reflecting damage to RNA
during bubble cavitation in the impinger. Although all methods
were subject to considerable variance, the most consistent measure
of aerosolized virus in the viral aerosol was viral RNA collected on
PTFE filters.
Since initial ferret exposures to aerosolized NC99 virus resulted
in very mild infection (see below Table 2), and since filters were
uniformly negative for culturable virus after 60 min collection, we
Table 1. Comparison of impinger and PTFE filter efficiencies for culturable virus and viral RNA.
Sample Source: impinger Filter Filter Ratio
d
Aerosol time
a FFU/collection
b FFU/collection
c GEq RNA/collection FFU:RNA
10 min 4.9 (0–19.6) E+03 4.9 (0.2–12.5) E+03 2.0 (0.9–3.9) E+06 1:411
20 min 16.2 (0–28.5) E+03 12.2 (5.0–25.0) E+03 4.2 (2.3–7.6) E+06 1:344
30 min 35.7 (19.5–49.3) E+03 4.0 (3.0–5.5) E+03 6.8 (4.1–9.1) E+06 1:1705
aVirus NC99 was nebulized in 6 experiments with impinger alone and 9 experiments with impinger and PTFE filter collections in parallel. The mean (range) total dose
nebulized was 1.8 (1.1–2.2)610
7 FFU, calculated by virus concentration in Collison at beginning of aerosol generation times fluid volume nebulized for each run.
bImpinger collection measured for 5.4 (range 5.3–5.5) L/min, reported as total FFU collected during interval of nebulization. N=5 at each time point as one outlier value
was removed from each group.
cPTFE filter collection combines two filters in parallel for total flow of 4.0 L/min, reported as total FFU and total genome equivalents (GEq) of RNA measured by T5000
assay.
dRatio of group means of FFU and GEq RNA collected respectively.
doi:10.1371/journal.pone.0024448.t001
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PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24448Figure 2. Characteristics of the aerosol exposure system. a. Photograph of exposure apparatus during nebulization with Collison generator
inside the origin chamber shows the visible cloud of airborne particles in both the left (origin) and right (recipient) chambers. Placement of the
Collison generator outside of the origin chamber, connected with 20 cm tubing, resulted in no visible suspended airborne particles in the chambers,
and all subsequent experiments reported here had this configuration. The Grimm particle spectrometer is placed on top of the left chamber and the
sampling port is located on top of the tunnel. b. The number particle size distribution with GRIMM optical counter. The fitted bimodal distribution
has the median diameters of 0.44 and 1.70 mm, and geometric standard deviation of 1.25 and 1.46, for the two size modes, respectively. c. Particle
number concentrations detected by Grimm laser-based particle counter sampled during four 30–60 sec intervals of the continuous one-hour
nebulization.
doi:10.1371/journal.pone.0024448.g002
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calculating a ratio between viable virus and viral RNA. The ratio
of virus:viral RNA ratio of 1:344 (Table 1) after 20 min of
collection on filters was used in subsequent analyses. In other
sources of virus-containing samples highly variable ratios are
calculated. The ratios in impinger collections varied from 1:7 to
1:0.16, reflecting both the variable virus collections as well as viral
RNA levels two orders of magnitude lower than comparable
filters. Ratios in the virus stock solutions in this study were 1:44,
and after 1 h of nebulization ratios of liquid remaining in the
Collison were 1:1050, probably due to loss of viability during
bubble cavitation. Thus losses of viable virus in the Collison jets,
on the walls of the first chamber and tunnel (confirmed by post-
nebulization sampling), and loss of viability due to higher humidity
resulted in less than 1% of the nebulized virus reaching the ferret
chamber.
Detection of ferret infection after exposure
Ferrets were exposed to varying levels of nebulized virus to
identify the aerosol ID50. No ferret exposed to nebulized virus
expressed any symptoms of infection. In the first six ferrets
exposed to high levels of aerosolized virus, humidity was not
controlled during nebulization and evidence for infection was
weak, with 5/8 (62%) seroconverting but only one ferret had
culturable virus in the nasal wash (Table 2). For the last two
ferrets in group 2 the humidity was reduced by insertion of the
diffusion dryer downstream from the Collison. Exposure did not
result in positive upper airway cultures, but levels of viral RNA
were high (.10
4 GEq/collection) for all nasal wash and throat
swab samples for days 1 through 5 post exposure. This
observation suggested that viral replication was established and
continuing in upper respiratory tract mucosa but viable virus was
not detectable in the nasal wash. Subsequent exposures to lower
levels of aerosolized virus utilized the arbitrary definition of
‘‘infection’’ to be the presence of high levels of viral RNA (.7
log10 GEq/collection) for all 5 days post-exposure (Table 3).
Lack of upper airway culturable virus could be due to a greater
portion of virus inhaled into the lung resulting in seroconversion,
but ferrets humanely euthanized 3 days post exposure had
negative cultures and RNA assays in lung tissue. To support the
notion that viral RNA present in washings for 5 days after
exposure represented viral replication in the mucosa, even though
cultures of nasal washes were negative, aliquots of 2610
7 FFU
NC99 were exposed to ultraviolet light for 10 min rendering the
preparation culture-negative on MDCK cells yet the RNA titer
remained at approximately 10
9 GEq/inoculation sample. Three
ferrets were inoculated with 10
9 GEq of viral RNA and nasal
washes collected 1, 2, and 3 days later. Post-inoculation nasal
washes were negative for detectable viral RNA, while the RNA
inoculation aliquot stored at room temperature for 48 h in nasal
wash solution remained detectable, suggesting that viral RNA is
cleared from the respiratory mucosa within 24 h.
Figure 3. Comparison of sensitivity of the T5000 and RT-PCR
Assays. Comparison of sensitivity of the assays for samples expected
to contain relatively higher concentrations (3.0 to 7.0 log10 Geq) of viral
RNA (throat swab and nasal wash) and relatively lower concentrations
(1.0 to 4.0 log10 Geq) of viral RNA. The Ibis T5000 Influenza assay was
not significantly more sensitive for detecting viral RNA in the airway
specimens under the conditions of this experimental infection, but was
significantly more sensitive in detection viral RNA in filter and impinger
aerosol collection devices (Chi-Squared test, p,0.01).
doi:10.1371/journal.pone.0024448.g003
Table 2. Evidence of Infection among Ferrets exposed to high levels of nebulized NC99.
Exp.-Ferret
Log10 virus
nebulized Change In RH
a
Aerosol vRNA
GEq
Calculated
b Inhaled virus
FFU/hour
Nasal wash
cFFU RNA HAI titer Day 12 pe
1 – A 7.00 45–80% nd - 0 nd ,20
-B 7.31 45–80% nd - 200 nd 320
-C 7.05 45–80% nd - 0 nd 320
-D 7.05 45–80% nd - 0 nd ,20
2 – A 7.08 42–75% 6.06 382 0 8.19 ,20
-B 7.08 42–75% 6.27 2688 0 6.77 320
-C 5.06 41–53% 5.01 145 0 8.08 320
-D 7.11 41–53% 5.67 407 0 7.28 320
aFor exposures to ferrets 2-C and 2-D, the diffusion dryer was inserted into the line exiting the Collison generator, reducing the humidity at the end of the hour
nebulization.
bCalculation of inhaled virus based on measured viral RNA in aerosol inhaled during 60 min of aerosol exposure.
cNasal wash was collected on day 2 post exposure (pe) in Exp 1, and daily in Exp 2; culture results are reported for the entire collection as FFU/mL; viral RNA is the peak
titer on day 3 pe and is reported as GEq/collection.
doi:10.1371/journal.pone.0024448.t002
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All ferrets inhaling more than 10 virus particles had sustained
viral RNA in upper airways but no positive cultures while 5/12
(42%) ferrets exposed to very low levels of viral aerosol had similar
levels of sustained viral RNA (Table 3). The aID50 was estimated
using Proc Probit in SAS to be 4 FFU with a 95% confidence
interval between 1.8 and 186. Thus higher aerosol exposures to
this seasonal H1N1 virus initiated seroconversion and mucosal
replication, and lower exposures initiated at least mucosal
replication but did not likely result in contagious infection.
Discussion
Few studies have quantified the aID50 by nebulized influenza
virus either in humans or in animal models. In a study performed
over 40 years ago human volunteers were exposed to nebulized
seasonal H3N2 influenza virus and the mean infectious aerosol
dose was calculated to be 0.3 to 6 TCID50 [6]. The minimum
infectious dose by intranasal drops was determined in susceptible
volunteers to be substantially higher than the calculated aerosol
ID50 [27–30]. Ferrets exposed to aerosolized H3N2 virus were
readily infected by inhaled doses of approximately 1 TCID50 [7].
This low dose is comparable to the minimal infecting dose of 5
virus particles for an H3N2 strain in guinea pigs [15]. We report
here that for an aerosolized seasonal H1N1 virus strain 4 FFU may
initiate viral replication in the nasal mucosa, and exposure to more
than 100 FFU resulted in seroconverson, neither higher nor low
doses led to contagious infection. These results must be interpreted
with respect to experimental design, limitations in aerosolized virus
detection, and the characteristics of the influenza strain studied.
Exposure apparatus designs will likely affect measured trans-
mission efficiencies. Our design restricted inhalation to droplet
nuclei particles less than 5 mm in aerodynamic diameter by
passage through a settling chamber and a tunnel. This design
could have prevented inhalation of virus in larger droplets and
subsequent culture-positive contagious infection. Air sampling was
placed as close to the ferret as possible in a small chamber to
increase the fraction of inhaled-to-delivered aerosol, but this
approach is less exact than a nose-only exposure. Whole-body
exposure for 1 h by unrestrained, unanaethetized ferrets was
chosen to mimic the conditions of transmission experienced by
humans in their daily activities. The advantages of this design
include natural respiration patterns, expected dilution of airborne
virus by deposition on the inanimate environment, and longer
exposures to low concentrations of virus in the aerosol. The
disadvantages include inability to exclude exposure by the non-
inhalation routes, loss of variable amounts of aerosolized virus on
chamber surfaces, and the need for surface decontamination
between exposures. These disadvantages are advantages of the
nose-only exposure systems [7,8,31], but the reduced minute
ventilation of the ferret sleeping in the conical restraint may alter
the amount or mucosal distribution of inhaled virus.
Detection of influenza virus in exhaled aerosols or nebulized
aerosols presents multiple challenges. Humans exhale droplets of
widely varying size and quantity [11]. Influenza RNA was
detected in aerosols exhaled from 3 of 5 individuals infected with
influenza A [5], and the exhaled virus was quantified as 20 RNA
particles per minute in one subject. In a study capturing 3 cough
specimens from ambulatory subjects with acute influenza A, 81%
had viral RNA detected by M segment RT-qPCR in the cough
droplets but only 2 of 21 had culturable virus [32]. We observed
the same discrepancy between viable virus and viral RNA
collection, with several possible explanations. Airborne virus has
a very low death rate constant if the humidity is low [33] and this
constant increases only modestly with increasing RH [34].
Exposures in this study were conducted at RH between 30–
50%, and significant inactivation by humidity was not likely. Viral
particles secreted into tissue culture media consists primarily of
non-infectious particles with only 1% as infectious particles [35–
37] and wide variation depending on cell source and culture
conditions. Thus high levels of non-infectious viral particles
nebulized from the stock solutions grown in tissue culture, and
additional viral particle disruption due to high velocity passage
through the Collison nebulizer jets, may dominate the collection at
low levels of viral aerosol.
The accurate measurement of airborne virus depends on a
number of experimental variables and the methods used to
capture airborne virus. The PTFE filter is more efficient than the
AGI impinger in capturing viral RNA but significantly less
efficient in capturing infectious particles [38]. For brief intervals of
collection we found the PTFE filter efficiently captured viable
virus but after 20 min viability appeared to decrease but we
demonstrated this only at high aerosolized virus levels. Indirect
estimate of viable virus content using the ratio of infectious particle
Table 3. Evidence of viral replication in ferrets exposed to low doses of aerosolized NC99.
Exp.- ferret
Target (a) Dose
Nebulized
Aerosol virus On filter/h
GEq/collection
Calculated (b) inhaled
virus FFU/hour
Peak nasal wash virus RNA
GEq/collection
Upper airway Viral
replication
3–A 1 610
3 ,2.0 ,2 4.89 2
-B 1610
3 ,2.0 ,2 3.54 2
-C 1610
5 3.38 10 9.00 +
-D 1610
5 3.38 10 7.05 +
4–A 1 610
4 2.87 3 7.53 +
-B 1 610
4 2.58 2 7.02 +
-C 1 610
4 3.04 5 7.61 +
-D 1 610
4 3.13 6 ,2.0 2
-E 1 610
4 2.86 3 ,2.0 2
5– A RE1 610
3 (N=5) ,2.0 ,2 ,2.0 2
a. Actual dose calculated was within 30% of target dose.
b. Calculations based on viral RNA collected on PTFE filter during 60 min of aerosol exposure.
doi:10.1371/journal.pone.0024448.t003
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viral loads. Although this ratio is subject to variability, use of
impinger collections to estimate the ratio was not valid due to the
large loss of detectable viral RNA in impinger fluid.
For rapid high-throughput assessment of airborne influenza
virus in environmental samples, culture may lack sufficient
sensitivity. In this study the T5000
TM Biosensor system demon-
strated markedly higher sensitivity than standard RT-qPCR in
samples expected to contain low levels of virus. The high
specificity and sensitivity of Biosensor system has been published
for diverse respiratory pathogens [22–24]. The breadth of
coverage and resolution offered by this influenza panel was shown
by testing 92 different influenza virus isolates, including 22 avian
isolates (representing twenty different H/N types collected from
nine different species of wild birds), 18 human influenza A isolates
(eight H1N1, 10 H3N2), four swine isolates (including one novel
type), one equine isolate, and six human influenza B isolates.
Despite the diversity of this sample set, the broad-range primers
generated amplicons from all isolates, while the base composition
signatures from amplicons obtained with these primers distin-
guished the isolates [23]. In samples derived from clinical isolates
at Northwestern University Hospital, the Biosensor system
detected infection with approximately 94% sensitivity and 99%
specificity. The detection of 6 genomic RNA segments by this
assay may correlate sufficiently accurately with airborne virus
levels and should be tested in environmental contamination
studies.
The observation of persistent viral RNA in upper airway
samples, seroconversion, yet negative cultures in ferrets may imply
that aerosol transmission is not simply a dose-dependent event.
Aerosol transmission may also depend on the behavior of the
inhaled virus, due to strain-dependent virulence or the widely
dispersed deposition of aerosolized virions. Humans infected with
H3N2 strains are generally more symptomatic than those infected
with seasonal H1N1 strains. Ferrets exposed to a seasonal H3N2
strain aerosol were infected by very low doses, shed infectious virus
in upper airway secretions, and displayed typical symptoms [7],
while ferrets in this study exposed to a range of aerosol doses of a
seasonal H1N1 virus failed to produce airway virus or display
symptoms. In our comparison of replication efficiency in human
bronchial epithelial cells, this seasonal H1N1 strain produced 100-
fold less infectious virus than the H1N1 2009 pandemic strain
[39]. Moreover, in a comparison of ferret-to-ferret aerosol
transmission of these two seasonal and pandemic H1N1 strains,
the seasonal strain was not transmitted under experimental
conditions permitting efficient transmission of the pandemic
strain, despite the fact that the infected ‘donor’ ferrets exhaled
higher levels of seasonal virus than pandemic virus (unpublished
data). Furthermore, high levels of 2009 H1N1 vRNA.10
7 Geq in
nasal wash collections were accompanied by positive viral cultures
.10
3 FFU/collection. Thus aerosol transmission may be deter-
mined more by the innate strain-dependent replication efficiency
in the susceptible host rather than the amount of virus exhaled by
the contagious source.
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